Table 2.
Observed and expected number of cancers, standardized incidence ratios, and confidence intervals among all pilots
| Cancer site (ICD-10) | Obs | Exp | SIR | (95% CI) |
|---|---|---|---|---|
| All (C00-C97, D09-D47a) | 83 | 92.49 | 0.90 | 0.71 to 1.11 |
| Oesophagus (C15) | 2 | 1.73 | 1.16 | 0.13 to 4.18 |
| Stomach (C16) | 3 | 3.96 | 0.76 | 0.15 to 2.21 |
| Colon and rectum (C18, C20) | 7 | 9.18 | 0.76 | 0.31 to 1.57 |
| Gallbladder (C23) | 1 | 0.10 | 10.15 | 0.13 to 56.46 |
| Larynx (C32) | 1 | 0.85 | 1.17 | 0.02 to 6.52 |
| Bronchus and lung (C33, C34) | 5 | 10.88 | 0.46 | 0.15 to 1.07 |
| Bone (C41) | 2 | 0.09 | 22.45 | 2.52 to 81.06 |
| melanoma (C43) | 7 | 2.12 | 3.31 | 1.33 to 6.81 |
| Other skin cancer (C44) | 4 | 3.75 | 1.07 | 0.29 to 2.73 |
| Penis (C60) | 1 | 0.31 | 3.18 | 0.42 to 17.72 |
| Prostate (C61) | 28 | 24.92 | 1.12 | 0.75 to 1.62 |
| Kidney (C64) | 5 | 4.22 | 1.18 | 0.40 to 2.92 |
| Bladder (C67) | 4 | 6.55 | 0.61 | 0.16 to 1.56 |
| Eye (C69) | 1 | 0.25 | 3.95 | 0.05 to 21.97 |
| Brain (C71, D33) | 4 | 1.69 | 2.37 | 0.64 to 6.06 |
| Thyroid gland (C73) | 3 | 1.41 | 2.13 | 0.43 to 6.23 |
| Cancer without specification of site (C80) | 3 | 1.62 | 1.85 | 0.37 to 5.40 |
| Mature T/NK-cell lymphomas (C84.6) | 1 | 0.32 | 3.13 | 0.04 to 17.43 |
| Chronic lymphocytic leukaemia of B-cell type (C91.1) | 1 | 0.94 | 1.06 | 0.01 to 5.91 |
| Acute myeloid leukaemia (C92.0) | 1 | 0.64 | 1.56 | 0.02 to 8.69 |
| Not included in all cancers: | ||||
| Basal cell carcinoma of the skin (C44) | 31 | 12.44 | 2.49 | 1.69 to 3.54 |
Abbreviations: International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10), observed (Obs), expected (Exp), standardized incidence ratio (SIR), and confidence interval (CI)
aRelated to brain: D09, D30, D35, D41, D32–33, D42–43, D44 and D46–47